Iterum Therapeutics Plc Stock Performance

Iterum Therapeutics Relative Risk vs. Return Landscape

If you would invest  42.00  in Iterum Therapeutics PLC on November 24, 2025 and sell it today you would lose (21.00) from holding Iterum Therapeutics PLC or give up 50.0% of portfolio value over 90 days. Iterum Therapeutics PLC is currently does not generate positive expected returns and assumes 5.3644% risk (volatility on return distribution) over the 90 days horizon. In different words, 48% of stocks are less volatile than Iterum, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon.Given the investment horizon of 90 days Iterum Therapeutics is expected to under-perform the market. In addition to that, the company is 7.25 times more volatile than its market benchmark. It trades about -0.18 of its total potential returns per unit of risk. The Dow Jones Industrial is currently generating roughly 0.15 per unit of volatility.

Iterum Therapeutics Target Price Odds to finish over Current Price

Given the investment horizon of 90 days the stock has the beta coefficient of 2.29 . This usually indicates as the benchmark fluctuates upward, the company is expected to outperform it on average. However, if the benchmark returns are projected to be negative, Iterum Therapeutics will likely underperform. Additionally Iterum Therapeutics PLC has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the Dow Jones Industrial.

Predictive Modules for Iterum Therapeutics

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Iterum Therapeutics PLC. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.

Hype Prediction Low Estimated High 0.01 0.22 5.63 Details

Intrinsic Valuation Low Real High 0.08 1.53 6.94 Details

Naive Forecast Low Next High 0 0.20 5.61 Details

1 Analysts Consensus Low Target High 5.01 5.50 6.11 Details

Iterum Therapeutics Risk Indicators

For the most part, the last 10-20 years have been a very volatile time for the stock market. Iterum Therapeutics is not an exception. The market had few large corrections towards the Iterum Therapeutics' value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Iterum Therapeutics PLC, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Iterum Therapeutics within the framework of very fundamental risk indicators.

Iterum Therapeutics Alerts and Suggestions

In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Iterum Therapeutics for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Iterum Therapeutics PLC can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.

Iterum Therapeutics Price Density Drivers

Iterum Therapeutics Fundamentals Growth

Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Iterum Therapeutics PLC. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real. You can also try the Global Markets Map module to get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes.

Understanding Iterum Therapeutics PLC requires distinguishing between market price and book value, where the latter reflects Iterum's accounting equity. The concept of intrinsic value - what Iterum Therapeutics' is actually worth based on fundamentals - guides informed investors toward better entry and exit points. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Market sentiment, economic cycles, and investor behavior can push Iterum Therapeutics' price substantially above or below its fundamental value.

Please note, there is a significant difference between Iterum Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Iterum Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. In contrast, Iterum Therapeutics' trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.